Article
Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse
1 Aug 2012
Abstract excerpt
Biomarkers are needed to address overtreatment that occurs for the majority of prostate cancer patients that would not die of the disease but receive radical treatment. A possible barrier to biomarker discovery may be the polyclonal/multifocal nature of prostate tumors as well as cell-type heterogeneity between patient samples. Tumor-adjacent stroma (tumor microenvironment) is less affected by genetic alteration...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
